Principais Deliberações do Conselho de Administração da CMVM
RegCanary analysis of a CMVM publication
Why it matters
RegCanary's analysis of what this means for regulated firms.
Two new collective investment vehicles were authorised — a bond fund under Santander Asset Management's SGOIC and an open-ended alternative fund under Heed Capital — while Altos Equity Partners secured registration as a EuVECA-qualified venture capital manager. For compliance teams, the more telling item is the closure of follow-up supervision across five entities regarding their self-assessment of governance and internal control systems. Closure signals that CMVM's scrutiny of governance frameworks is active, evidence-based and time-bound: firms should expect self-assessments to be tested, and remediation to be tracked to completion rather than accepted at face value.
The voluntary dissolution of Bem Comum and lapse of its authorisation is a reminder that wind-down and deregistration carry their own notification obligations. What this means in practice: asset managers planning new sub-funds or vehicles should ensure product governance, delegation oversight and internal control documentation are filing-ready before submission; managers considering the EuVECA label should confirm capital, qualifying-investment and disclosure requirements are met; and all in-scope firms should treat governance self-assessments as a live supervisory tool, retaining audit trails of actions taken. No immediate regulatory change arises for UK or cross-border firms, but Portugal-based groups and those with Iberian distribution should factor these approvals into product-launch and governance planning.
Actions: review internal control self-assessment evidence, monitor CMVM follow-up expectations, and confirm deregistration/notification steps for any entity exiting the market.
Who this affects
Sectors and firm types identified in the analysis.
- General Regulation
Source
CMVM
Original publication, 18 November 2026
Read the original publication cmvm.ptThis is RegCanary's analysis, not the regulator's text. It summarises and interprets the publication above; it is not the CMVM's original wording, and it is not legal advice. Always rely on the original source.